These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 1710442

  • 1. Anti-allergic effects of ketanserin on animal models of allergic reactions.
    Nagai H, Suda H, Kitagaki K, Goto S, Miura T, Koda A.
    Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
    [Abstract] [Full Text] [Related]

  • 2. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B.
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [Abstract] [Full Text] [Related]

  • 3. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T, Yamamura H, Kohno S, Ohata K.
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [Abstract] [Full Text] [Related]

  • 4. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
    Yamamura H, Kohno S, Ohata K.
    Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
    [Abstract] [Full Text] [Related]

  • 5. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
    Terasawa M, Goto K, Maruyama Y.
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
    [Abstract] [Full Text] [Related]

  • 6. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
    Yanagihara Y, Abe T, Edanami K, Agata M, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
    [Abstract] [Full Text] [Related]

  • 7. Action of tioxamast on various models of anaphylactic shock, hyperreactivity and bronchial inflammation in guinea-pigs.
    Tarayre JP, Aliaga M, Barbara M, Tisseyre N, Tisné-Versailles J, Couzinier JP.
    Arch Int Pharmacodyn Ther; 1991 Jan; 310():142-61. PubMed ID: 1772326
    [Abstract] [Full Text] [Related]

  • 8. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K, Akagi M, Izushi K, Mio M.
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [Abstract] [Full Text] [Related]

  • 9. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T, Saito T, Tajima S, Shimohara K, Ito K.
    Arzneimittelforschung; 1984 Oct; 34(7):805-10. PubMed ID: 6208915
    [Abstract] [Full Text] [Related]

  • 10. [Effect of KC-404 on allergic reactions types I-IV].
    Nishino K, Hara S, Irikura T.
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):291-9. PubMed ID: 6235160
    [Abstract] [Full Text] [Related]

  • 11. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
    Koda A, Nagai H, Mori H, Inagaki N, Nishiyori T, Matsuura N, Iwamoto T, Furukawa K, Yamada H, Goto S.
    Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
    [Abstract] [Full Text] [Related]

  • 12. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF, Hope WC, O'Donnell M, Baruth H, Crowley HJ, Miller DA, Yaremko B.
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [Abstract] [Full Text] [Related]

  • 13. Acute effects of deflazacort and its metabolite 21-desacetyl-deflazacort on allergic reactions.
    Omote M, Sakai K, Mizusawa H.
    Arzneimittelforschung; 1994 Feb; 44(2):149-53. PubMed ID: 7511903
    [Abstract] [Full Text] [Related]

  • 14. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals.
    Ishii K, Yakuo I, Seto Y, Kita A, Nakamura H, Nishikawa Y.
    Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286
    [Abstract] [Full Text] [Related]

  • 15. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs.
    Leibowitz M, Gordon RJ, Wolf PS, Sonnino-Goldman P.
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506
    [Abstract] [Full Text] [Related]

  • 16. [Effect of neurotropin (NSP) on allergic reactions (author's transl)].
    Koda A, Nagai H, Kurimoto Y, Yamada T, Mori H, Nishiyori T, Inagaki N.
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):319-34. PubMed ID: 6173291
    [Abstract] [Full Text] [Related]

  • 17. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K, Kamei C, Akagi M, Mio M, Shirasaka T, Chokki M.
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [Abstract] [Full Text] [Related]

  • 18. Anti-allergic properties of ethyl-3-methoxyphenyl-4-thiazolyl-2-oxamate (F 1865).
    Tarayre JP, Lauressergues H, Fauran F.
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):165-76. PubMed ID: 6187305
    [Abstract] [Full Text] [Related]

  • 19. Antiallergic activity of picumast dihydrochloride in several animal species.
    Roesch A, Schaumann W, Wilhelms OH.
    Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
    [Abstract] [Full Text] [Related]

  • 20. [Effects of KC-404 on bronchial anaphylactic reactions].
    Nishino K, Ohashi M, Hara S, Suzuki S, Irikura T.
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):281-9. PubMed ID: 6745809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.